Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

NCT00510042

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +11 more
Locations: Academic Medical Center Amsterdam Amsterdam, Netherlands

VU University Medical Center Amsterdam, Netherlands

Amphia Hospital Breda, Netherlands

Maxima Medical Center Eindhoven, Netherlands

View Trial Details

Completed

Modified Ultrafiltration in Cardiac Surgery

NCT00998647

Conditions: Blood Loss, Cardiovascular Diseases, Coagulopathy, +10 more
Locations: Goethe University hospital, Clinic for Anaesthesioloy Frankfurt am Main, Germany

View Trial Details

Completed

BAY14-2222 Continuous Infusion in Surgeries

NCT00606060

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Tel Litwinsky, Israel

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

NCT00002792

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +23 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

IFM 99-02 Thalidomide in Myeloma

NCT00222053

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Médecine Interne, CHU Purpan Toulouse, France

Médecine Interne, Hôpital Rangueil Toulouse, France

Rhumatologie, CHU Purpan Toulouse, France

Rhumatologie, CHU Rangueil Toulouse, France

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

NCT00255710

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions